Connection

Diane Descamps to HIV-2

Back to Details
This is a "connection" page, showing publications Diane Descamps has written about HIV-2.
Diane Descamps
Connection Strength
0.644
HIV-2
  1. Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients. J Antimicrob Chemother. 2018 05 01; 73(5):1173-1176.
    View in: PubMed
    Score: 0.174
  2. Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads. J Virol Methods. 2018 07; 257:12-15.
    View in: PubMed
    Score: 0.172
  3. New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification. J Clin Microbiol. 2017 09; 55(9):2850-2857.
    View in: PubMed
    Score: 0.164
  4. New insights are game-changers in HIV-2 disease management. Lancet HIV. 2019 04; 6(4):e214.
    View in: PubMed
    Score: 0.046
  5. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). Clin Infect Dis. 2018 09 28; 67(8):1161-1167.
    View in: PubMed
    Score: 0.045
  6. Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases. Sci Rep. 2018 04 10; 8(1):5789.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.